Knee injection study for moderate to severe osteoarthritis pain
Part of Bones, joints & muscles, Pain clinical trials.
This study tests a new knee injection called CX-011 to see if it can reduce pain and improve function in people with knee osteoarthritis. It may be a good option if you have tried other treatments without enough relief.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 74 years old.
- You have knee osteoarthritis that shows on an X-ray and have had knee pain for more than 3 months.
- You have had pain on most days (more than 15 days) in the last month.
- You have tried at least 3 treatments for knee osteoarthritis (including at least 2 medications like pain relievers or injections) and they didn't help enough.
- Your knee pain is moderate to severe (for example, scoring 4 to 8 on a 0-10 scale).
- You are willing to avoid certain pain medications and treatments during the study, like NSAIDs, opioids, and steroid injections.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new investigational medicine injected into the knee to see if it is safe and tolerable for people with painful knee osteoarthritis. It may help reduce pain and improve knee function.
This study tests the safety of an experimental injection called OA-SYS for people with moderate to severe knee osteoarthritis. It may help if you have not had recent injections or certain other health problems.
This study tests a new cell-based injection (Allocetra) directly into the knee joint for people with moderate osteoarthritis who haven't benefited from other treatments. The goal is to reduce pain and improve knee function.
This study tests a new injection called 2107 to see if it helps reduce pain and improve function in people with mild to moderate knee osteoarthritis. If you're eligible, you'll receive the injection and be monitored for several months to see how it works.
This study tests if an injection made from amniotic fluid can reduce knee pain and improve function in people with moderate knee osteoarthritis. The goal is to give a long-lasting alternative to steroid or gel shots.
This Phase 2 study tests whether stem cell injections can reduce pain and improve symptoms in people with knee or hip osteoarthritis. You may be considered if you have moderate-to-severe pain despite trying standard treatments.
Hear when a new Osteoarthritis of the Knees trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.